Homrich & Berg’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $2.33M | Buy |
6,254
+1,122
| +22% | +$418K | 0.05% | 138 |
|
2021
Q2 | $1.96M | Buy |
5,132
+702
| +16% | +$268K | 0.05% | 153 |
|
2021
Q1 | $1.59M | Buy |
4,430
+3,734
| +536% | +$1.34M | 0.04% | 162 |
|
2020
Q4 | $223K | Sell |
696
-103
| -13% | -$33K | 0.01% | 361 |
|
2020
Q3 | $215K | Sell |
799
-184
| -19% | -$49.5K | 0.01% | 310 |
|
2020
Q2 | $259K | Sell |
983
-36
| -4% | -$9.49K | 0.01% | 267 |
|
2020
Q1 | $231K | Buy |
1,019
+16
| +2% | +$3.63K | 0.01% | 263 |
|
2019
Q4 | $303K | Buy |
+1,003
| New | +$303K | 0.01% | 298 |
|
2019
Q3 | – | Sell |
-780
| Closed | -$220K | – | 346 |
|
2019
Q2 | $220K | Sell |
780
-80
| -9% | -$22.6K | 0.01% | 323 |
|
2019
Q1 | $247K | Buy |
860
+36
| +4% | +$10.3K | 0.01% | 289 |
|
2018
Q4 | $216K | Sell |
824
-55
| -6% | -$14.4K | 0.01% | 277 |
|
2018
Q3 | $241K | Sell |
879
-37
| -4% | -$10.1K | 0.01% | 290 |
|
2018
Q2 | $218K | Buy |
+916
| New | +$218K | 0.02% | 294 |
|
2017
Q4 | – | Sell |
-2,206
| Closed | -$419K | – | 342 |
|
2017
Q3 | $419K | Buy |
+2,206
| New | +$419K | 0.03% | 204 |
|
2016
Q2 | – | Sell |
-1,695
| Closed | -$236K | – | 265 |
|
2016
Q1 | $236K | Buy |
1,695
+107
| +7% | +$14.9K | 0.02% | 229 |
|
2015
Q4 | $221K | Sell |
1,588
-51
| -3% | -$7.1K | 0.02% | 236 |
|
2015
Q3 | $229K | Buy |
+1,639
| New | +$229K | 0.02% | 231 |
|